Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release Breastfeeding
Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release is safe in breast-feeding or not.

What is Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release used for?


ARYMO ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see Warnings and Precautions (5.1)], reserve ARYMO ER for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. ARYMO ER is not indicated as an as-needed (prn) analgesic. ARYMO ER is an opioid agonist indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. (1) Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve ARYMO ER for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. (1) ARYMO ER is not indicated as an as-needed (prn) analgesic. (1)

Can I continue breastfeeding if I am using Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release? How long does it stays in breast milk?

Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release low risk for breastfeeding
Morphine sulfate is the one and only active ingredient present in Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release. Morphine sulfate in itself is a low risk drug for lactation so it is easy to understand that Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release also comes in category of Low Risk item while breastfeeding. Below is the summary of Morphine sulfate in breastfeeding.

Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release Breastfeeding Analsys


Morphine sulfate while Breastfeeding

Low Risk

CAS Number: 57-27-2

Excretion into breast milk is low (even lower when administered through Epidural Anesthesia). In addition, a low oral bioavailability makes that the amount present in the infant's plasma due to absorption from milk by the gut is low. Even though, level of drug has been found in the plasma of infants from treated mothers, harmful effects in the infants were not reported. Levels in the milk are lower and side-effects are fewer among infants whose mothers were treated with Morphine than with Pethidine. Some authorities consider Morphine as the elective opioid medication for breastfeeding mothers. Analgesia used during the birth process is related to a brief delayed of stage II of Lactogenesis (milk come-in). Morphine increases Prolactin level and may decrease Oxytocin level, but it would not be determinant for already established lactations. Avoidance of repetitive or chronic use and follow-up for somnolence and adequacy of infant nourishment is recommended. Bed-sharing should be avoid whenever this medication is used by parents. The American Academy of Pediatrics rates it as compatible with breastfeeding.


Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release Breastfeeding Analsys - 2


Morphine sulfate while Breastfeeding

CAS Number: 57-27-2

Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release and breastfeeding

Epidural morphine given to mothers for postcesarean section analgesia results in trivial amounts of morphine in their colostrum and milk. Intravenous or oral doses of maternal morphine in the immediate postpartum period result in higher milk levels than with epidural morphine. Labor pain medication may delay the onset of lactation. Maternal use of oral narcotics during breastfeeding can cause infant drowsiness, central nervous system depression and even death, although low-dose morphine might be preferred over other opiates.[1] Newborn infants seem to be particularly sensitive to the effects of even small dosages of narcotic analgesics. Once the mother's milk comes in, it is best to provide pain control with a nonnarcotic analgesic and limit maternal intake of morphine to a 2 to 3 days at a low dosage with close infant monitoring, especially in the outpatient setting.[2] If the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness, a physician should be contacted immediately.


Is Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release safe while breastfeeding

I am nursing mother and I have already used Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release, what should I do?

During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release then you shall inform your doctor, But you should not be worried too much as Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release comes in category of low risk drug.


My doctor has prescribed me Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release, what should I do?

Though Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release, will my baby need extra monitoring?

Not much


Who can I talk to if I have questions about usage of Arymo Er | Morphine Sulfate Tablet, Film Coated, Extended Release in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week